Somatic hypermutation of Ig variable region genes is initiated by activation-induced cytidine deaminase; however, the activity of multiple DNA polymerases is required to ultimately introduce mutations. DNA polymerase (Pol) has been implicated in mutations at A͞T, but polymerases involved in C͞G mutations have not been identified. We have generated mutant mice expressing DNA polymerase (Pol) specifically devoid of polymerase activity. Compared with WT mice, Polq-inactive (Polq, the gene encoding Pol) mice exhibited a reduced level of serum IgM and IgG1. The mutant mice mounted relatively normal primary and secondary immune responses to a T-dependent antigen, but the production of high-affinity specific antibodies was partially impaired. Analysis of the J H4 intronic sequences revealed a slight reduction in the overall mutation frequency in Polq-inactive mice. Remarkably, although mutations at A͞T were unaffected, mutations at C͞G were significantly decreased, indicating an important, albeit not exclusive, role for Pol activity. The reduction of C͞G mutations was particularly focused on the intrinsic somatic hypermutation hotspots and both transitions and transversions were similarly reduced. These findings, together with the recent observation that Pol efficiently catalyzes the bypass of abasic sites, lead us to propose that Pol introduces mutations at C͞G by replicating over abasic sites generated via uracil-DNA glycosylase.
F
unctional Ig genes are assembled in developing B cells by recombination-activating gene-mediated rearrangement of the germline V, D, and J gene segments (1) (2) (3) . This process generates a primary repertoire of B cells expressing diversified surface immunoglobulins. Upon antigen stimulation and in the presence of T cell help, B cells undergo further diversification of their Ig genes, namely somatic hypermutation (SHM) and class switch recombination (CSR), in the germinal centers (GCs) of secondary lymphoid organs such as spleen, lymph node, and Peyer's patches (4) . Both SHM and CSR are initiated by a single enzyme, activation-induced cytidine deaminase, which catalyzes the deamination of C to U on DNA and͞or possibly on an as-yet-hypothetical endonuclease mRNA (5) (6) (7) . Although the mechanism of SHM is still not fully understood, it is thought that mutations are ultimately introduced by error-prone DNA polymerases during the DNA repair process (7, 8) .
Approximately 10 new low-fidelity DNA polymerases have been identified in the past several years (9, 10) . DNA polymerase (Pol) is a Ϸ300-kDa family A polymerase with a unique structure, having a helicase domain in its N-terminal portion and a polymerase domain in its C terminus (11) (12) (13) . Polq, the gene encoding Pol, has a homolog in Drosophila, the mus308 gene (14) . Mutant flies exhibited hypersensitivity to DNA interstrand crosslinking agents such as cisplatinum but not to alkylating agents such as methyl methanesulfonate (15) . Seki et al. (13) recently purified human POLQ and examined its catalytic activity. POLQ has extremely low fidelity, making frequent errors on undamaged templates. Moreover, POLQ was shown to be the only enzyme to efficiently catalyze both the insertion and extension steps that allow bypass of abasic sites (16) .
The function of Pol in mammalian cells remains poorly understood. In a phenotype-based mutagenesis screen for chromosome instability mutants, Shima et al. (12) identified a mouse mutation called chaos1 (chromosome aberration occurring spontaneously), which exhibited elevated levels of spontaneous micronuclei in reticulocytes. The chaos1 mutation introduced a T-to-C base substitution in the Polq gene, which caused a serine-to-proline substitution at amino acid residue 1932 in this very large protein. Very recently, these investigators have generated Pol-deficient mice, which have a phenotype very similar to chaos1, thus confirming the identity of Polq and chaos1 (17) . Surprisingly, besides increased micronuclei in reticulocytes, the Pol-deficient mice did not show any obvious phenotype and displayed the same sensitivity as normal mice to the DNA crosslinking agent mitomycin C and to ␥-irradiation.
Unlike other low-fidelity DNA polymerases, which are ubiquitously expressed, human and mouse Polq exhibit a tissuespecific expression pattern. We found preferential expression in lymphoid tissues; most interestingly, abundant Polq transcripts were detected in GC B cells, the target cells for both SHM and CSR (18) . The lymphoid tissue-specific expression pattern of Polq in both human and mouse suggested that Pol might have a specialized role in mammalian lymphocytes.
To investigate the polymerase function of Pol in SHM, here we have generated mice specifically devoid of Pol polymerase activity (Polq-inactive), leaving helicase and other potentially important functional domains intact. Compared with WT mice, Polq-inactive mice exhibited a moderate decrease in overall mutation frequency in the J H 4 intronic sequence of responding B cells, a genomic region chosen for analysis to avoid antigenselection bias. Remarkably, however, only mutations at C͞G were specifically reduced in Polq-inactive mice, whereas mutations at A͞T were not affected. We propose that the polymerase activity of Pol mediates the generation of C͞G mutations by replicating over abasic sites formed by uracil-DNA glycosylasecatalyzed excision of the uracil residues generated by activationinduced cytidine deaminase.
Materials and Methods
Generation of Mice Lacking the Polymerase Core Domain. A targeting vector was constructed to replace exons 25 and 26 with the neomycin gene. R1 ES cells were transfected with the linearized targeting vector and 2 days after transfection cultured in the presence of 600 g͞ml G418 and 2 M ganciclovir (only for the first 2 days). ES colonies were expanded and subjected to Southern blot analysis to identify homologous recombination. The deletion of exons 25 and 26 was further confirmed by RT-PCR analysis by using primers s6623 (5Ј-AGCGG-GA A A AGCACCTGA AC-3Ј) and as7597 (5Ј-CGTCGT-GAAGTTGAAGGATG-3Ј). RT-PCR was performed at 95°C for 2 min followed by 30 cycles of amplification at 95°C for 5 s, 58°C for 10 s, and 72°C for 2 min by using Taq polymerase (Toyobo, Osaka). Chimera mice were bred with C57BL͞6N to obtain heterozygous mice. After backcrossing to C57BL͞6N for three generations, heterozygous mice were bred with each other to obtain homozygous mice. Mice were kept at specific pathogen-free conditions, and animal experiments were approved by the Animal Facility Committee of the RIKEN Yokohama Institute.
Assay for Polymerase Activity. Polyclonal rabbit antibodies were raised against a peptide (QNDRTGLLPKRKLKG) located near the C terminus of mouse Pol. For immunoprecipitation, 5 ϫ 10 7 spleen cells were incubated for 30 min on ice in 0.5 ml of lysis buffer, as described (16) The lysate was centrifuged for 10 min at 15,000 rpm, and the supernatant was precleared four times with 0.5 ml of protein A beads. The precleared lysate was incubated with 10 l of protein A beads at 4°C for 4 h and washed five times with the lysis buffer. Half of the washed beads were used for the polymerase assay and the remaining half of the beads for Western blot analysis. The polymerase assay was performed essentially as described by using 32 P-labeled 16 mer (5Ј-CACTGACTGTATGATG-3Ј) annealed to a 30 mer (5Ј-CTCGTCAGCATCTACATCATACAGTCAGTG-3Ј) oligonucleotide as a template (16) .
Flow Cytometry Analysis and Proliferation Assay. Flow cytometry analysis was performed as described (19) . For proliferation assays, B cells were purified by negative selection from spleen of 8-to 12-wk-old mice by using a B cell enrichment set (BD Biosciences, San Jose, CA). Stimulation with anti-IgM antibodies, CD40 ligand, and LPS and 3 H-thymidine uptake was essentially as described (20) .
Immune Response. Five WT and eight Polq-inactive mice (9-10 wk old) were injected i.p. with 100 g of 4-hydroxy-3-nitrophenyl-acetyl (NP) coupled to chicken gammaglobulin (NP-CGG) (Biosearch) precipitated with alum and boosted 4 wk later. Mice were bled weekly, and serum titers of NP-specific IgG1 were analyzed by ELISA, by using NP-specific monoclonal high-(clone C6) and low-(clone N1G9) affinity antibodies as a standard (21) .
SHM Assay. Five pairs of age-and sex-matched WT and Polqinactive mice (16 wk old) were immunized with 100 g of NP-CGG and 2 weeks later, B220 ϩ PNA ϩ GC B cells were sorted. All mice were IgM b/b as determined by FACS analysis of peripheral blood leukocytes by using allotype-specific antibodies (FITC anti-IgM a and PE-anti-IgM b , BD Biosciences). Genomic DNA was isolated from sorted GC B cells and amplified with forward primer J558Fr3 (5Ј-CAGCCTGACATCTGAG-GACTCTGC-3Ј) and reverse primer JHCHint (5Ј-CTCCAC-CAGACCTCTCTAGACAGC-3Ј), as described (22) . PCR was carried out with KOD-Plus polymerase (Toyobo) under the following conditions: 94°C for 5 min and then 94°C for 20 s, 65°C for 30 s, and 68°C for 70 s for 30 cycles. The PCR products were cloned into the pCR2.1 vector for sequencing. Only clones with unique V(D)J junctions were analyzed.
Results

Generation of Mice Specifically Devoid of Pol Polymerase Activity.
To specifically inactivate the DNA polymerase activity of Pol while leaving the helicase and other potentially important domains intact, we deleted exons 25 (185 base pairs) and 26 (112 base pairs), which encode a conserved aspartic acid residue known to be essential for the polymerase catalytic activity (23, 24) and the tyrosine residue that binds the incoming nucleotide (11, 14) , respectively ( Fig. 1 A and B) . Homologous recombination in ES cells was monitored by Southern blot analysis (Fig.  1C) . Because the deletion of these two exons was in-frame and the Polq promoter was intact, the targeted allele could theoretically be transcribed and translated. As predicted, RT-PCR analysis by using primers flanking exons 25 and 26 (s6623 and as7597, Fig. 1 A) gave rise to a 975-bp band in WT and a 678-bp band in mutant cells ( Fig. 2A) , although the level of mutant Polq was slightly reduced, possibly due to the intronic insertion of the neomycin gene. We further sequenced each of the two bands and confirmed that they were derived from WT mRNA and mRNA lacking exons 25 and 26 (data not shown). Consistent with the expression of the mutant mRNA, Western blot analysis revealed an immunoreactive protein in the mutant cells with a molecular weight similar to the WT Pol (Fig. 2B) . Because the antibodies used in this assay recognize an epitope near the C-terminal region of Pol, we conclude that mutant cells express a truncated Pol protein lacking the polymerase core domain at a slightly reduced level compared to WT cells.
To confirm that the mutant enzyme was devoid of DNA synthesis activity, we immunoprecipitated Pol from WT and mutant splenocytes. Western blot analysis revealed that a similar amount of WT and mutant Pol was immunoprecipitated from both samples (Fig. 2C) . As expected, WT (Fig. 2D, lane 4) , but not mutant (Fig. 2D, lane 5) , Pol exhibited a templatedependent polymerase activity. These results demonstrate that the mutant mice express a truncated Pol that has greatly reduced DNA polymerase activity but is likely intact for other potentially important functions.
Normal B Cell Development and Maturation in Polq-Inactive Mice.
FACS analysis of bone marrow cells revealed no significant differences in the percentages of B220 ϩ CD43 ϩ progenitor and B220 ϩ CD43 Ϫ IgM Ϫ precursor cells (Fig. 3A) . (Fig. 3B ). In addition, no apparent differences between WT and Polq-inactive mice were observed in the follicular (CD23 high CD21 dull ) and marginal zone (CD23 dull CD21 high ) B cells (Fig. 3B) . In our analysis of six pairs of WT and Polqinactive mice, we have found no significant differences in B and T lymphocyte development and function (data not shown). In addition to their normal frequency, Polq-inactive B cells were functionally normal, as assessed by proliferation in response to anti-IgM antibodies, LPS, and CD40 ligand (Fig. 3C) and to various combinations of these stimuli (not shown), although the response to low doses of anti-IgM stimulation appeared to be slightly reduced in Polq-inactive B cells. These results demonstrate that Polq-inactive B cells undergo normal differentiation and maturation and respond normally to an array of in vitro stimuli that signal through a variety of receptors, including the B cell antigen receptor, Toll-like receptor 4, and the surrogate for T cell help, CD40.
Reduction in Serum Ig Levels in Polq-Inactive Mice.
To analyze B cell function in vivo, we first measured the levels of serum Igs in nonimmunized mice. Except for IgA, we found a general reduction in serum Ig levels in Polq-inactive mice (Fig. 4) . The average Ig levels Ϯ SD (g͞ml) in WT and Polq-inactive mice were 262 Ϯ 
A Partial Impairment in the Production of High-Affinity Antibodies in
Polq-Inactive Mice. We then examined the primary and secondary immune responses to the T-dependent antigen NP-CGG. Polqinactive mice produced slightly reduced amounts of total (lowand high-affinity) anti-NP antibodies in both primary and secondary immune responses, as measured in an ELISA assay with NP 30 -BSA (Fig. 5A) . However, the production of high-affinity antibodies, as measured with NP 3 -BSA, was more clearly reduced in the Polq-inactive mice (Fig. 5B) . In fact, the observed reduction in the titers of total anti-NP antibodies could be explained by the reduction in the titers of high-affinity anti-NP antibodies. The reduced affinity maturation in Polq-inactive mice was further illustrated by comparing the ratio of NP 3 -and NP 30 -binding antibody titers (Fig. 5C) . We also examined the appearance of the B220 ϩ PNA ϩ GC B cells after NP-CGG immunization. Polq-inactive and WT mice contained a similar frequency of GC B cells in spleen on days 10 and 14 after antigen injection (data not shown). These results may suggest a defect in selection of high-affinity B cells in the GC or that the Polqinactive B cells have intrinsic defects in the SHM of Ig V genes.
A Selective Reduction of Mutations at C͞G in Ig Genes of Polq-Inactive
Mice. To gain insight into the mechanisms underlying the reduced levels of high-affinity antibodies, we immunized mice with NP-CGG, isolated the GC B cells, and examined SHM. We restricted our analysis to the intronic sequence downstream of the J H 4 region rather than the coding sequence of the V H 186.2 gene, which is the dominant V gene segment used in the NP response, because the V H 186.2 sequence is under strong antigendriven selection, hence the unselected mutation pattern would likely be obscured (22, 25, 26) . We analyzed 98 and 97 unique clones from WT and Polq-inactive mice, respectively ( Fig. 6A ; data for sequences are available upon request). Polq-inactive mice exhibited a slight reduction in the total mutation frequency in the J H 4 intron (Table 1) . However, when the mutation frequency of C͞G vs. A͞T mutations was calculated, we found that, whereas mutation frequency at A͞T was similar between WT and Polq-inactive mice (0.522% and 0.514%, respectively), C͞G mutation frequency was reduced by 41% (0.279% vs. 0.476% in WT mice, Table 1 ; Fig. 6B ). In fact, the reduction in the overall mutation frequency in Polq-inactive mice was solely attributable to the reduction in mutations at C͞G. The specific reduction of mutations at C͞G was further illustrated by calculating the ratio of AT:CG mutations, which was 1.097 in WT and 1.843 in Polq-inactive mice (Table 1) . Similarly, the relative representation of mutations at C͞G and A͞T was skewed ( Fig.  6C ; P Ͻ 0.001, 2 test). The reduction of mutations at C͞G was more focused on the intrinsic SHM hotspots (Fig. 6B) . In particular, the C͞G mutations at the four hotspots located at nucleotide positions 39, 47, 56, and 62 were all significantly reduced in Polq-inactive mice (Fig. 6B , P Ͻ 0.05). Both transition and transversion mutations were similarly affected in the Polqinactive mice (Fig. 6C) . No differences were observed in the ratio of transitions to transversions within C͞G and A͞T. These results indicate that the polymerase activity of Pol is important for the generation of mutations at C͞G.
Discussion
In the present study, we generated and analyzed mice expressing a mutant Pol specifically devoid of polymerase activity. To our knowledge, this represents a unique mutant mouse line to have reduced C͞G but relatively normal A͞T mutations. The active site, rather than a gene ablation mutagenesis strategy, was adopted, because we reasoned that in the complete absence of Pol, its function might be compensated for by other DNA polymerases. At least 10 lesion bypass DNA polymerases have been identified in higher eukaryotes. The presence of the mutant Pol could potentially prevent irrelevant DNA polymerases from taking part in the process of SHM and allow us to explore the requirement for the DNA synthesis activity of Pol in SHM. In this regard, it is possible that Pol-null mice might show a quite different phenotype as compared with our Polq-inactive mice.
B cell development and maturation were normal in Polqinactive mice. In addition, the Polq-inactive and WT B cells responded similarly to several different in vitro stimuli. Interestingly, we observed a reduction in serum Ig levels in nonimmunized mice, suggesting that Polq-inactive B cells might be partially impaired in CSR. In this regard, it is notable that mice deficient in msh2 or msh6, components of the mismatch repair pathway, exhibit a specific reduction in mutations at A͞T and also have defects in CSR (27, 28) . Although Pol contains a helicase-like domain, helicase activity, which is known to play a critical role in DNA replication and recombination, has not been experimentally verified. Because Polq-inactive mice express a mutant protein with intact helicase and other potentially important functional domains, it is unclear how a mutant Pol devoid of DNA synthesis activity might affect CSR. The reduction in the titer of serum IgM, which is mainly derived from B1 B cells, further suggests that Polq-inactive mice may have defects in the differentiation of specific B cell subpopulations.
Available evidence supports the DNA deamination model in which activation-induced cytidine deaminase deaminates C to U and generates a U͞G mismatch (27, (29) (30) (31) (32) (33) . This U͞G lesion is thought to be resolved by three distinct but related pathways (8, 34) . The phase 1a pathway generates G to A and C to T transitions by directly replicating over the U͞G mismatch where U is recognized as T. The phase 1b pathway generates both transitions and transversions at C͞G by replicating over the noninstructive abasic site formed after excision of U via uracil DNA glycosylase. U͞G mispair can also be recognized by components of the mismatch repair pathways and trigger a short-patch mutagenic DNA repair, leading to mutations at A͞T pairs (phase 2 pathway).
In all these scenarios, mutations are finally introduced by DNA polymerases. Indeed, a number of low-fidelity DNA polymerases have been implicated in SHM of Ig genes. Inhibition of DNA polymerase (Pol) expression by antisense RNA was shown to reduce overall mutation frequency, but not mutation pattern, in the CL-01 B cell line and in transgenic mice (35, 36) . DNA polymerase (Pol) has also been suggested to play a role in SHM in a GC-type Burkitt's lymphoma line (37) . However, 129 mice, which lack a functional Pol due to a nonsense mutation in the Poli gene, exhibit a normal frequency and pattern in Ig gene mutations (32, 38, 39) . Deficiency in DNA polymerase (Pol) has been shown to correlate with dramatically reduced mutations at A͞T pairs in both human and mice (32, 33, (40) (41) (42) . Pol does not seem to be involved in the mutations at C͞G pairs, because neither the frequency nor the spectrum at C͞G mutations was altered in the absence of Pol (32, 33) . These observations suggest that different DNA polymerases might be involved in different mutagenic pathways. Until now, however, a DNA polymerase(s) specifically involved in C͞G mutations has not been identified.
In the present study, we have shown that Pol, or more precisely its DNA synthesis activity, is important for the generation of mutations at C͞G pairs. These findings, together with the observations that human POLQ is the only enzyme that efficiently catalyzes both the insertion and the extension steps for bypass of abasic sites (16) , implicate Pol in the phase 1b mutagenic pathway. Biochemical analysis has demonstrated that POLQ preferentially inserts A opposite an abasic site (6) . If POLQ has the same catalytic specificity in vivo, then it would generate primarily G to A and C to T transitions. If so, inactivation of Pol polymerase activity should have resulted in fewer transitional mutations at C͞G. However, both transition and transversion mutations at C͞G were similarly reduced in the Polq-inactive mice. This observation suggested that C͞G transversions were also affected in Polq-inactive mice. It is conceivable that Pol may be able to insert nucleotides other than A opposite abasic sites under in vivo conditions where other necessary accessory factors are present. Indeed, recombinant human Pol and DNA polymerase (Pol) exhibited dramatically different catalytic properties, including DNA synthetic activity and ability to bypass an abasic site, when assayed in the presence of accessory factors PCNA, replication factor C and replication protein A (43, 44) . It is also possible that Pol may catalyze the extension step from mismatch termini formed by other low-fidelity polymerases, which may insert C and T, as well as A opposite an abasic site and generate both transition and transversion mutations. Disruption of Pol polymerase activity resulted in approximately one-third reduction in both transition and transversion mutations at C͞G pairs. Assuming that the transition mutations generated by phase 1a pathway are unaffected in Polq-inactive mice, Pol polymerase activity should generate most of the transition mutations and a part of the transversion mutations at C͞G in the phase 1b pathway. Therefore, a substantial portion of the transversion mutations at C͞G must be catalyzed by as-yet-unidentified DNA polymerases. Candidate enzymes include Rev1, which predominantly generates transversions at C͞G (45) and interestingly is up-regulated in GC B cells (unpublished results), and Pol, which is a mismatch extender (46) and has been implicated in both A͞T and C͞G mutations (35, 36) .
